Alan Crooks - Protect Pharmaceutical CEO, Director
PRTT Stock | USD 0.89 0.01 1.11% |
CEO
Mr. Alan Crooks is Chief Executive Officer, Director of the Company. A National and international recognized political and business consultant. Has been a key individual with the startup and expansion of several businesses internationally. His expertise in the political arena have been invaluable to the business he has helped. since 2019.
Tenure | 5 years |
Phone | 954 292 0033 |
Web | https://agropharmacy.com |
Similar Executives
Found 7 records | CEO Age | ||
Jeffrey Frelick | Bone Biologics Corp | 58 | |
Steven Foster | Tenon Medical | 56 | |
Gary Maharaj | SurModics | 61 | |
Robert Spignesi | Rapid Micro Biosystems | 54 | |
Michael Stewart | STRATA Skin Sciences | 67 | |
Sheri Dodd | Tactile Systems Technology | 58 | |
Dolev Rafaeli | STRATA Skin Sciences | 60 |
Protect Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Protect Pharmaceutical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Current Valuation | 2.6 M | |||
Shares Outstanding | 1.11 M | |||
Shares Owned By Insiders | 84.30 % | |||
Price To Earning | (23.96) X | |||
EBITDA | (115.4 K) | |||
Net Income | (122.61 K) | |||
Cash And Equivalents | 20.07 K | |||
Total Debt | 101 K | |||
Current Ratio | 0.40 X | |||
Book Value Per Share | (0.01) X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Protect Pink Sheet Analysis
When running Protect Pharmaceutical's price analysis, check to measure Protect Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protect Pharmaceutical is operating at the current time. Most of Protect Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Protect Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protect Pharmaceutical's price. Additionally, you may evaluate how the addition of Protect Pharmaceutical to your portfolios can decrease your overall portfolio volatility.